[
  {
    "sentence": "Subsequent exclusions included 1062 patients with undocumented chemotherapy status and 192 patients with missing survival data, yielding a final analytical cohort of 47,868 eligible participants (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Moreover, the RT group manifested substantially enhanced short- and long-term survival rates, with 1-year (98.5 % vs. 93.3 %), 3-year (94.0 % vs. 84.6 %), and 5-year (88.9 % vs. 76.8 %) survival probabilities (Fig. 2A), consistently in favor of the RT-treated patients.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Nevertheless, considering the limited number of patients receiving non-beam radiation therapies, these findings require cautious interpretation and warrant validation in larger prospective studies (Fig. 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Within this context, we systematically evaluated the association between primary tumor site and OS in the selected SEER cohort (Fig. 3A–B).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "As shown in Fig. 4A–F, RT conferred significantly greater survival outcomes in both ER-positive (ER+) and PR-positive (PR+) patients compared to their ER-negative (ER-) and PR-negative (PR-) counterparts.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Our analysis of RT outcomes across different age strata revealed consistent survival benefits in all age groups (Fig. 5A).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Notably, despite concerns regarding treatment tolerance in advanced age, the oldest subgroup exhibited the most pronounced survival improvement (Fig. 5B–C).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "To clarify this, we performed a stage-stratified analysis comparing overall survival between RT-treated and non-treated cohorts (Fig. 6A–D).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Subsequent exclusions included 1062 patients with undocumented chemotherapy status and 192 patients with missing survival data, yielding a final analytical cohort of 47,868 eligible participants (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Moreover, the RT group manifested substantially enhanced short- and long-term survival rates, with 1-year (98.5 % vs. 93.3 %), 3-year (94.0 % vs. 84.6 %), and 5-year (88.9 % vs. 76.8 %) survival probabilities (Fig. 2A), consistently in favor of the RT-treated patients.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Nevertheless, considering the limited number of patients receiving non-beam radiation therapies, these findings require cautious interpretation and warrant validation in larger prospective studies (Fig. 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Within this context, we systematically evaluated the association between primary tumor site and OS in the selected SEER cohort (Fig. 3A–B).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "As shown in Fig. 4A–F, RT conferred significantly greater survival outcomes in both ER-positive (ER+) and PR-positive (PR+) patients compared to their ER-negative (ER-) and PR-negative (PR-) counterparts.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Our analysis of RT outcomes across different age strata revealed consistent survival benefits in all age groups (Fig. 5A).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Notably, despite concerns regarding treatment tolerance in advanced age, the oldest subgroup exhibited the most pronounced survival improvement (Fig. 5B–C).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "To clarify this, we performed a stage-stratified analysis comparing overall survival between RT-treated and non-treated cohorts (Fig. 6A–D).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Subsequent exclusions included 1062 patients with undocumented chemotherapy status and 192 patients with missing survival data, yielding a final analytical cohort of 47,868 eligible participants (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Moreover, the RT group manifested substantially enhanced short- and long-term survival rates, with 1-year (98.5 % vs. 93.3 %), 3-year (94.0 % vs. 84.6 %), and 5-year (88.9 % vs. 76.8 %) survival probabilities (Fig. 2A), consistently in favor of the RT-treated patients.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Nevertheless, considering the limited number of patients receiving non-beam radiation therapies, these findings require cautious interpretation and warrant validation in larger prospective studies (Fig. 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Within this context, we systematically evaluated the association between primary tumor site and OS in the selected SEER cohort (Fig. 3A–B).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "As shown in Fig. 4A–F, RT conferred significantly greater survival outcomes in both ER-positive (ER+) and PR-positive (PR+) patients compared to their ER-negative (ER-) and PR-negative (PR-) counterparts.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Our analysis of RT outcomes across different age strata revealed consistent survival benefits in all age groups (Fig. 5A).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Notably, despite concerns regarding treatment tolerance in advanced age, the oldest subgroup exhibited the most pronounced survival improvement (Fig. 5B–C).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "To clarify this, we performed a stage-stratified analysis comparing overall survival between RT-treated and non-treated cohorts (Fig. 6A–D).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Subsequent exclusions included 1062 patients with undocumented chemotherapy status and 192 patients with missing survival data, yielding a final analytical cohort of 47,868 eligible participants (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Moreover, the RT group manifested substantially enhanced short- and long-term survival rates, with 1-year (98.5 % vs. 93.3 %), 3-year (94.0 % vs. 84.6 %), and 5-year (88.9 % vs. 76.8 %) survival probabilities (Fig. 2A), consistently in favor of the RT-treated patients.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Nevertheless, considering the limited number of patients receiving non-beam radiation therapies, these findings require cautious interpretation and warrant validation in larger prospective studies (Fig. 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Within this context, we systematically evaluated the association between primary tumor site and OS in the selected SEER cohort (Fig. 3A–B).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "As shown in Fig. 4A–F, RT conferred significantly greater survival outcomes in both ER-positive (ER+) and PR-positive (PR+) patients compared to their ER-negative (ER-) and PR-negative (PR-) counterparts.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Our analysis of RT outcomes across different age strata revealed consistent survival benefits in all age groups (Fig. 5A).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Notably, despite concerns regarding treatment tolerance in advanced age, the oldest subgroup exhibited the most pronounced survival improvement (Fig. 5B–C).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "To clarify this, we performed a stage-stratified analysis comparing overall survival between RT-treated and non-treated cohorts (Fig. 6A–D).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Subsequent exclusions included 1062 patients with undocumented chemotherapy status and 192 patients with missing survival data, yielding a final analytical cohort of 47,868 eligible participants (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Moreover, the RT group manifested substantially enhanced short- and long-term survival rates, with 1-year (98.5 % vs. 93.3 %), 3-year (94.0 % vs. 84.6 %), and 5-year (88.9 % vs. 76.8 %) survival probabilities (Fig. 2A), consistently in favor of the RT-treated patients.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Nevertheless, considering the limited number of patients receiving non-beam radiation therapies, these findings require cautious interpretation and warrant validation in larger prospective studies (Fig. 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Within this context, we systematically evaluated the association between primary tumor site and OS in the selected SEER cohort (Fig. 3A–B).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "As shown in Fig. 4A–F, RT conferred significantly greater survival outcomes in both ER-positive (ER+) and PR-positive (PR+) patients compared to their ER-negative (ER-) and PR-negative (PR-) counterparts.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Our analysis of RT outcomes across different age strata revealed consistent survival benefits in all age groups (Fig. 5A).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Notably, despite concerns regarding treatment tolerance in advanced age, the oldest subgroup exhibited the most pronounced survival improvement (Fig. 5B–C).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "To clarify this, we performed a stage-stratified analysis comparing overall survival between RT-treated and non-treated cohorts (Fig. 6A–D).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Subsequent exclusions included 1062 patients with undocumented chemotherapy status and 192 patients with missing survival data, yielding a final analytical cohort of 47,868 eligible participants (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Moreover, the RT group manifested substantially enhanced short- and long-term survival rates, with 1-year (98.5 % vs. 93.3 %), 3-year (94.0 % vs. 84.6 %), and 5-year (88.9 % vs. 76.8 %) survival probabilities (Fig. 2A), consistently in favor of the RT-treated patients.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Nevertheless, considering the limited number of patients receiving non-beam radiation therapies, these findings require cautious interpretation and warrant validation in larger prospective studies (Fig. 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Within this context, we systematically evaluated the association between primary tumor site and OS in the selected SEER cohort (Fig. 3A–B).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "As shown in Fig. 4A–F, RT conferred significantly greater survival outcomes in both ER-positive (ER+) and PR-positive (PR+) patients compared to their ER-negative (ER-) and PR-negative (PR-) counterparts.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Our analysis of RT outcomes across different age strata revealed consistent survival benefits in all age groups (Fig. 5A).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Notably, despite concerns regarding treatment tolerance in advanced age, the oldest subgroup exhibited the most pronounced survival improvement (Fig. 5B–C).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "To clarify this, we performed a stage-stratified analysis comparing overall survival between RT-treated and non-treated cohorts (Fig. 6A–D).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Subsequent exclusions included 1062 patients with undocumented chemotherapy status and 192 patients with missing survival data, yielding a final analytical cohort of 47,868 eligible participants (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Moreover, the RT group manifested substantially enhanced short- and long-term survival rates, with 1-year (98.5 % vs. 93.3 %), 3-year (94.0 % vs. 84.6 %), and 5-year (88.9 % vs. 76.8 %) survival probabilities (Fig. 2A), consistently in favor of the RT-treated patients.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Nevertheless, considering the limited number of patients receiving non-beam radiation therapies, these findings require cautious interpretation and warrant validation in larger prospective studies (Fig. 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Within this context, we systematically evaluated the association between primary tumor site and OS in the selected SEER cohort (Fig. 3A–B).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "As shown in Fig. 4A–F, RT conferred significantly greater survival outcomes in both ER-positive (ER+) and PR-positive (PR+) patients compared to their ER-negative (ER-) and PR-negative (PR-) counterparts.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Our analysis of RT outcomes across different age strata revealed consistent survival benefits in all age groups (Fig. 5A).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Notably, despite concerns regarding treatment tolerance in advanced age, the oldest subgroup exhibited the most pronounced survival improvement (Fig. 5B–C).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "To clarify this, we performed a stage-stratified analysis comparing overall survival between RT-treated and non-treated cohorts (Fig. 6A–D).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Subsequent exclusions included 1062 patients with undocumented chemotherapy status and 192 patients with missing survival data, yielding a final analytical cohort of 47,868 eligible participants (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Moreover, the RT group manifested substantially enhanced short- and long-term survival rates, with 1-year (98.5 % vs. 93.3 %), 3-year (94.0 % vs. 84.6 %), and 5-year (88.9 % vs. 76.8 %) survival probabilities (Fig. 2A), consistently in favor of the RT-treated patients.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Nevertheless, considering the limited number of patients receiving non-beam radiation therapies, these findings require cautious interpretation and warrant validation in larger prospective studies (Fig. 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Within this context, we systematically evaluated the association between primary tumor site and OS in the selected SEER cohort (Fig. 3A–B).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "As shown in Fig. 4A–F, RT conferred significantly greater survival outcomes in both ER-positive (ER+) and PR-positive (PR+) patients compared to their ER-negative (ER-) and PR-negative (PR-) counterparts.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Our analysis of RT outcomes across different age strata revealed consistent survival benefits in all age groups (Fig. 5A).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Notably, despite concerns regarding treatment tolerance in advanced age, the oldest subgroup exhibited the most pronounced survival improvement (Fig. 5B–C).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "To clarify this, we performed a stage-stratified analysis comparing overall survival between RT-treated and non-treated cohorts (Fig. 6A–D).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Subsequent exclusions included 1062 patients with undocumented chemotherapy status and 192 patients with missing survival data, yielding a final analytical cohort of 47,868 eligible participants (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Moreover, the RT group manifested substantially enhanced short- and long-term survival rates, with 1-year (98.5 % vs. 93.3 %), 3-year (94.0 % vs. 84.6 %), and 5-year (88.9 % vs. 76.8 %) survival probabilities (Fig. 2A), consistently in favor of the RT-treated patients.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Nevertheless, considering the limited number of patients receiving non-beam radiation therapies, these findings require cautious interpretation and warrant validation in larger prospective studies (Fig. 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Within this context, we systematically evaluated the association between primary tumor site and OS in the selected SEER cohort (Fig. 3A–B).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "As shown in Fig. 4A–F, RT conferred significantly greater survival outcomes in both ER-positive (ER+) and PR-positive (PR+) patients compared to their ER-negative (ER-) and PR-negative (PR-) counterparts.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Our analysis of RT outcomes across different age strata revealed consistent survival benefits in all age groups (Fig. 5A).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Notably, despite concerns regarding treatment tolerance in advanced age, the oldest subgroup exhibited the most pronounced survival improvement (Fig. 5B–C).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "To clarify this, we performed a stage-stratified analysis comparing overall survival between RT-treated and non-treated cohorts (Fig. 6A–D).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Subsequent exclusions included 1062 patients with undocumented chemotherapy status and 192 patients with missing survival data, yielding a final analytical cohort of 47,868 eligible participants (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Subsequent exclusions included 1062 patients with undocumented chemotherapy status and 192 patients with missing survival data, yielding a final analytical cohort of 47,868 eligible participants (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Moreover, the RT group manifested substantially enhanced short- and long-term survival rates, with 1-year (98.5 % vs. 93.3 %), 3-year (94.0 % vs. 84.6 %), and 5-year (88.9 % vs. 76.8 %) survival probabilities (Fig. 2A), consistently in favor of the RT-treated patients.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Nevertheless, considering the limited number of patients receiving non-beam radiation therapies, these findings require cautious interpretation and warrant validation in larger prospective studies (Fig. 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Moreover, the RT group manifested substantially enhanced short- and long-term survival rates, with 1-year (98.5 % vs. 93.3 %), 3-year (94.0 % vs. 84.6 %), and 5-year (88.9 % vs. 76.8 %) survival probabilities (Fig. 2A), consistently in favor of the RT-treated patients.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Nevertheless, considering the limited number of patients receiving non-beam radiation therapies, these findings require cautious interpretation and warrant validation in larger prospective studies (Fig. 2B).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel B",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Within this context, we systematically evaluated the association between primary tumor site and OS in the selected SEER cohort (Fig. 3A–B).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Within this context, we systematically evaluated the association between primary tumor site and OS in the selected SEER cohort (Fig. 3A–B).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel A",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "As shown in Fig. 4A–F, RT conferred significantly greater survival outcomes in both ER-positive (ER+) and PR-positive (PR+) patients compared to their ER-negative (ER-) and PR-negative (PR-) counterparts.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "As shown in Fig. 4A–F, RT conferred significantly greater survival outcomes in both ER-positive (ER+) and PR-positive (PR+) patients compared to their ER-negative (ER-) and PR-negative (PR-) counterparts.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Our analysis of RT outcomes across different age strata revealed consistent survival benefits in all age groups (Fig. 5A).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Notably, despite concerns regarding treatment tolerance in advanced age, the oldest subgroup exhibited the most pronounced survival improvement (Fig. 5B–C).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Our analysis of RT outcomes across different age strata revealed consistent survival benefits in all age groups (Fig. 5A).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Notably, despite concerns regarding treatment tolerance in advanced age, the oldest subgroup exhibited the most pronounced survival improvement (Fig. 5B–C).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel B",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "To clarify this, we performed a stage-stratified analysis comparing overall survival between RT-treated and non-treated cohorts (Fig. 6A–D).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "To clarify this, we performed a stage-stratified analysis comparing overall survival between RT-treated and non-treated cohorts (Fig. 6A–D).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      }
    ]
  }
]